All News #Library
Rare Diseases
Belite Bio Finishes Enrolling Patients In Tinlarebant Trial
27 Jan 2026 //
GLOBENEWSWIRE
Belite Brings FDA Filing Into View with Phase 3 Stargardt Win
01 Dec 2025 //
PRESS RELEASE
Belite Bio Gets Conditional UK Approval For Tinlarebant
02 Nov 2025 //
GLOBENEWSWIRE
Belite Bio Gets Priority Review From China NMPA For Tinlarebant
15 Oct 2025 //
GLOBENEWSWIRE
Belite Ends 2-Year Ph 3 Tinlarebant Trial in Stargardt Disease
12 Sep 2025 //
GLOBENEWSWIRE
Belite Bio Completes Enrollment in Global Phase 3 PHOENIX Trial
02 Jul 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support